Biotech · Private company
iTeos Belgium SA
Track this companyFree. Adds iTeos Belgium SA to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- DostarlimabPhase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- EOS-448Phase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- inupadenantPhase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- SOC chemotherapiesPhase 2 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- Anticancer agentPhase 1 · Selected Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- EOS006215Phase 1 · Selected Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid TumorsPHASE1 · TERMINATED · started Apr 7, 2025ClinicalTrials.gov NCT06877533 · fetched Nov 12, 2026
- Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 26, 2022ClinicalTrials.gov NCT05403385 · fetched Nov 12, 2026
- Study of Novel Regimens in Relapsed or Refractory Multiple MyelomaPHASE1 · TERMINATED · started May 1, 2022ClinicalTrials.gov NCT05289492 · fetched Nov 12, 2026
- Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid TumorsPHASE1_PHASE2 · UNKNOWN · started Sep 6, 2021ClinicalTrials.gov NCT05060432 · fetched Nov 12, 2026
- First-in-Human Study of EOS100850 (Inupadenant) in Patients with CancerPHASE1 · COMPLETED · started Feb 5, 2019ClinicalTrials.gov NCT03873883 · fetched Nov 12, 2026
- Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)PHASE2 · COMPLETED · started Jan 24, 2019ClinicalTrials.gov NCT03739710 · fetched Nov 12, 2026
- Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1PHASE2 · COMPLETED · started Jan 24, 2019ClinicalTrials.gov NCT05553808 · fetched Nov 12, 2026